LIPOCALIN-2 AS A PROGNOSTIC AND DIAGNOSTIC MARKER FOR HEART AND STROKE RISKS

Methods and apparatus are disclosed for the measurement of lipocalin-2 in body fluid (including but not limited to blood, serum, plasma, urine, saliva, tear, etc) by an assay such as a immunoassay or an immunotest for (1) the prediction of risk of future cardiovascular diseases and (2) the determina...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LEHMANN, MATTHIAS, XU, AIMIN, RENNEBERG, REINHARD, CAUTHERLEY, GEORGE WILLIAM HUNTER, CHAN, PUIYEE, CANGEL, WANG, YU
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS TESTING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Methods and apparatus are disclosed for the measurement of lipocalin-2 in body fluid (including but not limited to blood, serum, plasma, urine, saliva, tear, etc) by an assay such as a immunoassay or an immunotest for (1) the prediction of risk of future cardiovascular diseases and (2) the determination of the likelihood that certain individuals will benefit to a greater o lesser extent from the use of certain treatments designed to prevent and/or treat cardiovascula diseases. La présente invention concerne des procédés et des appareils pour la mesure de la lipocaline 2 dans un fluide corporel (comprenant, mais sans y être limité, le sang, le sérum, le plasma, l'urine, la salive, les larmes, etc.) par un essai tel qu'un immunoessai ou un test immunologique pour (1) la prédiction du risque de maladies cardiovasculaires futures et (2) la détermination de la probabilité que certains individus profitent à un degré plus ou moins élevé de l'utilisation de certains traitements conçus pour prévenir et/ou traiter des maladies cardiovasculaires.